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Mycophenolate mofetil (MMF ) is a new immunoMethods. Rat and human MCs were growth-arrested suppressive agent which is effective in preventing acute by withdrawal of fetal calf serum ( FCS ) and stimulated allograft rejection by inhibiting lymphocyte proliferaby addition of FCS, platelet-derived growth factor tion [1] [2] [3] [4] . In vitro studies showed that the antiprolifer-(PDGF ) or lysophosphatidic acid (LPA). Different ative effect of MMF and of its active metabolite concentrations of MMF (0.019-10 mM ) were added mycophenolic acid is mediated through reversible concomitantly in the presence or absence of guanosine.
inhibition of inosine monophosphate dehydrogenase MC proliferation was determined by [3H ]thymidine (IMPDH ), which is the key enzyme of purine synthesis incorporation. Cell viability was assessed by trypan in lymphocytes [5, 6 ] . Application of MMF in a restenblue exclusion. Apoptotic nuclei were stained using the osis injury model of the carotid artery suggested an Hoechst dye H33258. Cytosolic free Ca2+ concentraadditional antiproliferative effect of MMF in vascular tions were determined with the fluorescent calcium smooth-muscle cells [7] . chelator fura-2-AM.
Renal mesangial cells (MCs) are located in the Results. MMF inhibited mitogen-induced rat MC propericapillary mesangial space of the glomerular capilliferation with an IC 50 of 0.45±0.13 mM. Human MCs lary tuft and can be considered as specialized smoothproved to be even more sensitive (IC 50 0.19±0.06 mM ). muscle cells [8] . During inflammatory glomerular disInhibition of MC proliferation was reversible and eases MCs take part in the disease process by enhanced not accompanied by cellular necrosis or apoptosis.
secretion of growth factors, increased cell proliferation Addition of guanosine prevented the antiproliferative and matrix deposition leading to glomerular scarring effect of MMF, indicating that inhibition of IMPDH [9, 10] . In kidney biopsies of patients with mesangial is responsible for decreased MC proliferation. Early proliferative glomerulonephritis, proliferation of MCs signalling events of GTP-binding-protein-coupled and deposition of extracellular matrix represent promreceptors, such as changes in intracellular Ca2+ levels inent histopathological changes [11, 12] . Specific inhibiwere not affected by MMF.
tion of MC proliferation combined with an antiConclusions. The results show that MMF has a coninflammatory mode of action could be a therapeutic centration-dependent antiproliferative effect on culapproach to limit disease progression of mesangial tured MCs in the therapeutic range, which might be a proliferative glomerulonephritis. In the present study, rationale for the use of this drug in the treatment of we investigated the effect of MMF on DNA synthesis mesangial proliferative glomerulonephritis. 
Reagents

Detection of apoptosis and necrosis of mesangial cells
Stock solutions of mycophenolate mofetil (MMF, 5 mg/ml, Rat MCs were seeded in 5 cm Petri dishes (200 000 cells in kindly provided by Roche, Palo Alto, USA), mycophenolic 3 ml/well ), allowed to attach for 24 h, growth-arrested for acid and guanosine (Sigma, Deisenhofen, Germany) were 24 h and restimulated for addtional 24 h with 10% FCS in made by solubilization in dimethyl sulphoxide (DMSO).
the presence or absence of MMF (0.6 mM ), guanosine Potential effects of DMSO on MC growth were assessed by (100 mM ) or 0.6 mM MMF plus 100 mM guanosine. Then appropriate controls. Hoechst 33258, lysophosphatidic acid the cells were scraped off the culture plates and after centrifu-(LPA) and MCDB 302 medium were obtained from Sigma, gation the pellet was fixed with 100 ml 3% paraformaldehyde Deisenhofen, Germany. All other cell culture materials were for 5 min and brought onto glass slides coated with 2% 3-from Biochrom (Berlin, Germany). Human recombinant aminopropyl-triethoxysilane dissolved in acetone. Samples platelet-derived growth factor BB (PDGF BB) was kindly were stained for 5 min with 8 mg/ml of the Hoechst dye provided by Dr J. Hoppe (Biozentrum University of H33258, which stains DNA in nuclei, washed with PBS and Wü rzburg, Germany). All other substances were from commounted in glycerol gelatin. Nuclei were visualized using a mercial sources and of highest analytical grade available.
Leica-type Labovert microscope and 100 nuclei were counted on each slide [16 ] . Cell viability was assessed by trypan blue
Cell culture exclusion according to standard procedures.
Rat MCs were isolated, characterized, and cultured as Determination of cytosolic free calcium concentration described by Lovett et al. [13] . Cells were grown in DMEM supplemented with 2 mM -glutamine, 5 mg/ml insulin, 4,5 g/l Cytosolic free Ca2+ concentrations were determined essenglucose, 100 U/ml of penicillin, and 100 U/ml streptomycin tially as described previously [17] . Serum-deprived rat MCs containing 10% FCS and were growth-arrested by serum were washed in phosphate-buffered saline (PBS) and trypdeprivation in DMEM without FCS. For the experiments, sinized with trypsin/EDTA. MCs in suspension were loaded MCs were used between passages 10 and 25. Human MCs with the fluorescent calcium chelator fura-2-AM (final conwere isolated and cultured as described previously [14] . centration 4 mM ) (Sigma, Deisenhofen, Germany). During Human MCs were maintained in RPMI 1640 supplemented measurements, mesangial cells were kept in suspension in with 5 mg/ml insulin, 5 mg/ml transferrin, 1×non-essential Ca2+-containing assay buffer (140 mM NaCl, 10 mM amino acids, 1 mM sodium pyruvate, 2 mM -glutamine, HEPES, pH 7.4, 1 mM NaH 2 PO 4 , 5 mM KCl, 1 mM MgSO 4 , 100 U/ml penicillin and 100 U/ml streptomycin containing 1 mM CaCl 2 , 5.5 mM glucose). Fluorescence measurements 10% FCS. Cells between passages 3 and 12 were used for were made using a Kontron SFM25 spectral fluorometer. experiments. Cells were growth-arrested in MCDB 302, The excitation wavelength was set to 340 nm, and emission supplemented with 5 mg/ml insulin, 5 mg/ml transferrin, 100 was monitored at 510 nm. Maximum and minimum fluores-U/ml of penicillin and 100 U/ml streptomycin without FCS. cence of fura-2 were determined by lysing the cells (2 ml
Human vascular smooth-muscle cells (SMCs) from the total volume) with 20 ml 10% triton X-100/PBS and by iliac artery of an organ donor were obtained from the Coriell adding 24 mM EGTA, 1.4 mM Tris, pH 8.4 respectively. Institute for Medical research (Camden NJ ). The smooth-The Kd of fura-2 for Ca2+ was assumed to be 225 nM [18] . muscle cell nature of the cultures was confirmed by immunofluorescence staining for a-actin and negative staining for Statistics factor VIII related antigen. SMCs were cultured in medium M199, enriched with 20% (FCS), 0.1 mg/ml bovine hypothalExperiments were repeated at least three times with different amic growth factor (ECGF ), 1 mM sodium pyruvate, batches of cell preparations. Representative data or means± 0.05 mg/ml heparin, 100 U/ml penicillin and 100 U/ml strep-SD of independent experiments are shown. IC 50 values were tomycin. The SMCs were used for experiments between obtained by fitting of the data to the general dosepassages 8 and 15 [15] .
response equation for a single binding component [19] . Unpaired Student's t test was used for statistical analysis.
Cell proliferation studies
Results with levels of P<0.05 were considered significant. a concentration-dependent decrease of PDGF-, LPA-, of MMF indicated that MMF was not cytotoxic. Viability of cells was also confirmed by their ability to and FCS-stimulated proliferation: 2.5 mM MMF, a concentration which is in the therapeutic range of extrude trypan blue. More than 95% of control and MMF-treated cells (10 mM ) extruded trypan blue and this immunosuppressant caused >90% inhibition of PDGF-, LPA-, or FCS-stimulated rat MC prolifera-were viable (data not shown). Possible effects of MMF on MC apoptosis were examined by staining of cell tion. Similar effects were also observed with mycophenolic acid, the active metabolite of MMF (data not nuclei with the Hoechst dye H33258. MMF did not induce DNA fragmentation even if the highest concenshown). Therefore in all subsequent experiments, 10% FCS and MMF were used for cell proliferation studies. tration of MMF (10 mM ) used for proliferation assays was administered for 24 h. The number of apoptotic cells was less than 10% under all conditions tested Concentration-dependence of the antiproliferative effect (data not shown). of mycophenolate mofetil on rat and human mesangial cells Effect of mycophenolate mofetil on human vascular A concentration-dependent inhibition of FCS-induced smooth-muscle cell proliferation cell proliferation was observed in rat ( Figure 2A ) and human MCs ( Figure 2B ). In rat MCs more than 90% As MCs are closely related to SMCs, the action of MMF on FCS-stimulated growth of human SMCs was of cell proliferation was inhibited by therapeutically relevant concentrations between 2.5 and 10 mM MMF. investigated. The proliferation rate of SMCs was reduced to 43±8% (n=3) at the maximal concentraThe concentration of MMF for 50% inhibition of [3H ]thymidine incorporation (IC 50 ) was calculated to tion of 10 mM MMF. These data indicate that the antiproliferative effect of MMF on human MCs was 0.45±0.12 mM (means±SD, n=3). Cell numbers were accordingly reduced by MMF (data not shown). When much more pronounced than its effect on human SMCs. The proliferation rate of human umbilical vein the IC 50 of human MCs (0.19±0.06 mM; n=3) was compared with that of rat MCs, it turned out to be endothelial cells was also investigated but did not change significantly at concentrations up to 10 mM significantly lower (P<0.
05). Maximal inhibition of [3H ]thymidine incorporation into human MCs of MMF (data not shown).
>90% was already present at a therapeutic concentration of 0.6 mM.
Dependence of the antiproliferative effect of mycophenolate mofetil on GTP-depletion Reversibility of the antiproliferative effect of
As IMPDH inhibition is the primary mechanism of mycophenolate mofetil action of MMF in human lymphocytes [6, 11] , we tested whether the antiproliferative effect of MMF The inhibitory effect of MMF on FCS-stimulated proliferation was completely reversible, when cells were in MCs was dependent on guanosine depletion.
Guanosine alone did not significantly affect cell proliffirst treated with MMF for 24 h and then incubated with fresh culture medium containing 10% FCS with-eration. When FCS-stimulated cell proliferation was set to 100% (7259±593 c.p.m. for rat MCs and out MMF for additional 24 h ( Figure 3 ). The ability of MCs to recover from the growth-inhibitory effect 2319±118 c.p.m. for human MCs; n=3; Figure 4A ,B), pholipase C and subsequent release of Ca2+ from internal stores which is dependent on trimeric GTPbinding proteins [17] . To determine possible effects of MMF on early signalling steps in MCs, ATP-and serotonin-stimulated increase of cytosolic free calcium concentrations was determined. As an example, the ATP-mediated biphasic increase in intracellular Ca2+ is shown in Figure 5 (ATP 100 mM ). There was no alteration when the MCs had been preincubated with MMF (10 mM ) overnight. Analogous results were obtained with 1 mM serotonin (data not shown). enzyme of guanine nucleotide synthesis [6, 15] . Lymphocytes are thought to be especially sensitive to proliferation with guanosine alone was 97±27% for GTP depletion because these cells, unlike most other rat MCs and 100±7% for human MCs. FCS-induced cells, rely on the de novo pathway for purine synthesis MC proliferation that had been inhibited by 0.6 mM and are not able to synthesize guanosine nucleotides MMF to 36±4% in rat MCs and to 10±2% in human by salvage from the adenine or guanine nucleotide MCs could be completely restored when guanosine pathways [5, 20] . Therefore, the immunosuppressive was added together with MMF (92±10% in rat and effect of MMF in humans, which is based on IMPDH 93±12% in human MCs). These data indicate that the inhibition, is associated with a marked decrease in growth-inhibitory effect of MMF on MCs is mediated lymphocyte proliferation. by IMPDH inhibition.
While most previous studies have focused on the action of MMF on cells of the immune system, in this Effect of mycophenolate mofetil on early GTPstudy we demonstrate a novel type of action of MMF, dependent signalling in mesangial cells namely its concentration-dependent inhibition of the proliferative response of rat and human MCs to differIncubation of MCs with ATP or serotonin leads to a rapid activation of phosphatidylinositol-specific phos-ent mitogens, such as PDGF, which are also involved in inflammatory processes in vivo. The antiproliferative effect of MMF is not solely dependent on the inhibiton of IMPDH, but also on the capacity of cells to synthesize purine nucleotides by the salvage pathway rather than the de novo pathway of guanosine synthesis [2] . The metabolic activity of these different pathways has not yet been investigated in MCs. However, our experiments clearly show that the effect of MMF is due to GTP depletion, because addition of exogenous guanosine as source for IMPDH-independent GTP synthesis completely reversed the MMF-mediated inhibiton of MC proliferation. In contrast MMF had no antiproliferative effect on human umbilical venous endothelial cells. This observation is in agreement with a previous study in which we showed that the effect of MMF on cell adhesion molecules in human endothelial cells was not reversed by addition of exogenous guanosine [21] . Both studies suggest that in endothelial cells the salvage pathway for guanosine synthesis might be more active than in vascular smooth-muscle and mesangial cells.
Although GTP depletion led to an almost complete cessation of DNA synthesis in mesangial cells, as evidenced by [3H ]thymidine uptake, there was no effect on GTP-dependent signalling: preincubation of MCs with 10 mM MMF did not interfere with ATP-stimulated release of Ca2+ from internal stores, which is mediated by purinergic receptors that are coupled to trimeric GTP-binding proteins [17] . The antiproliferative effect of MMF on MCs did not depend on the mitogenic stimulus used. At about 1 mM MMF, inhibition was the same for PDGF binding to tyrosine kinase receptors as for lysophosphatidic acid, which induces proliferation by binding to receptors that couple to trimeric GTP-binding proteins [22] . These data support the notion that MMF does not critically interfere proliferation was fully reversible when MMF-treated MCs were subsequently restimulated with FCS. These in vitro data are in accordance with observations in vivo which showed that MMF treatment is not associated with cytotoxic effects on glomerular cells [23] . On the contrary, in this rat model of chronic allograft rejection, glomerular sclerosis and proteinuria were reduced in MMF-treated animals in comparison with the control group [23] .
Compared to other non-lymphoid cells tested, human MCs proved to be especially sensitive to the inhibitory effect of MMF (IC 50 about 200 nM ). The therapeutically relevant blood trough levels of MMF are in the low micromolar range corresponding to 
